Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 72 results found. Search for [ Remdesivir study ]

Results 1 to 21 of 72
BusinessToday.In
November 9, 2020
Researchers made their discovery while developing highly sensitive antibody tests for COVID-19. They compared the blood of COVID-19 patients with that of patients who had not had the disease


Reuters
October 16, 2020
The American company said the data appeared inconsistent, the findings were premature and that other studies had validated the drug's benefits


BusinessToday.In
October 16, 2020
Coronavirus impact: The report said that the treatment could only partially improve the UK patient's impairment. It must be mentioned here that the \"rapid and unexplained\" deafness apparently only affects one ear


BusinessToday.In
October 16, 2020
Two separate studies published in the journal Blood Advances on Wednesday, October 14 indicated that people with blood type O are also at lower risk of developing severe symptoms, including organ complications


BusinessToday.In
October 16, 2020
The WHO said that the Solidarity trial looked at the effects of these treatments on overall mortality, initiation of ventilation, and duration of hospital stay in hospitalised patients


Reuters
October 14, 2020
Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc that he received for his COVID-19, as tantamount to a cure in a video he posted last week


BusinessToday.In
October 14, 2020
India Stock Market Highlights Today: Tata Steel, Bharti Airtel, HCL Tech, Asian Paints and Bajaj Auto were among the top laggards today. On the other hand, ONGC, followed by NTPC, PowerGrid, UltraTech Cement, ITC, HDFC Bank, ICICI Bank and HDFC were among the top gainers.


Reuters
September 13, 2020
A deal for Immunomedics, whose cancer therapy Trodelvy is FDA-approved as a third-line treatment for an aggressive type of breast cancer called Metastatic Triple-Negative Breast Cancer, could be announced Monday if not sooner


Reuters
September 12, 2020
The Food and Drug Administration has allowed more liberal remdesivir use, but 6 out of 8 major hospital systems contacted by Reuters said they were not using it for moderate cases


Reuters
July 31, 2020
Gilead's second-quarter sales fell nearly 10% from a year earlier to $5.1 billion, short of the average analyst estimate of $5.3 billion, according to Refinitiv


E Kumar Sharma
July 29, 2020
With this, close to 10 players -- Glenmark, Cipla and Dr Reddy's and others -- are either in the market or soon to launch. Currently, the drug is being sold in prices ranging between Rs 39 and Rs 75 per tablet for 200mg


Prasanna Mohanty
July 27, 2020
Profit-driven enterprises are ill-suited to protect the health and life of a vast majority of people, as the US and Indian governments experience, but do precious little, thereby failing in their primary duty


BusinessToday.In
July 22, 2020
Coronavirus treatment: Patients who were administered Glenmark's FabiFlu saw 40 per cent faster achievement of clinical cure


PB Jayakumar
July 21, 2020
Glenmark says compared to other therapies approved for emergency use in COVID-19 in India, FabiFlu is much more economical and an effective treatment option; DCGI had earlier asked it to clarify on allegation that the drug was unaffordable due to its high pricing


Associated Press
July 20, 2020
For months before studies like these, learning what helps or harms has been undermined by \"desperation science\" as doctors and patients tried therapies on their own or through a host of studies not strong enough to give clear answers


BusinessToday.In
July 10, 2020
Coronavirus vaccine news update: Serum Institute of India that is producing around four vaccine candidates including the Oxford University-AstraZeneca coronavirus candidate has said that it is expected to launch a candidate by the end of six months


Reuters
July 9, 2020
Remdesivir was granted emergency use authorization in the United States to treat severe cases of COVID-19 in patients who are hospitalized


BusinessToday.In
July 8, 2020
Coronavirus vaccine update: Twelve hospitals have been chosen for COVAXIN trials in the country. Bharat Biotech's COVAXIN is undergoing quality and safety tests before the doses are administered to volunteers


BusinessToday.In
July 8, 2020
Coronavirus crisis: The researchers also point out that future outcomes would be more dependent on the willingness of people and governments to reduce transmission than tests


PTI
July 8, 2020
\"The idea that this is a dangerous drug is just silly, but if you ask the American people based on the media's coverage of it, that is kind of the state of play right now,\" he said


PAGES 1 OF 4  1234